58 participants
Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC Treatment
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-07-21
- Start Date:
- 2021-07-31
- Completion:
- 2024-07-30
Conditions
- Lung Cancer Stage II
Interventions
- DRUG
No Results Yet